J, F., E, S., J, T., S, S., M, E., & KJ, N. (2026). Impact of Elexacaftor/Tezacaftor/Ivacaftor on Systemic Antibiotic Utilization in Pediatric Patients With Cystic Fibrosis. Pediatric pulmonology, 61(8), e71749. https://doi.org/10.1002/ppul.71749
Παραπομπή σε μορφή Chicago (17η εκδ.)J, Fava, Stephan E, Tansmore J, Sheikh S, Eisner M, και Novak KJ. "Impact of Elexacaftor/Tezacaftor/Ivacaftor on Systemic Antibiotic Utilization in Pediatric Patients With Cystic Fibrosis." Pediatric Pulmonology 61, no. 8 (2026): e71749. https://doi.org/10.1002/ppul.71749.
Παραπομπή σε μορφή MLA (9th εκδ.)J, Fava, et al. "Impact of Elexacaftor/Tezacaftor/Ivacaftor on Systemic Antibiotic Utilization in Pediatric Patients With Cystic Fibrosis." Pediatric Pulmonology, vol. 61, no. 8, 2026, p. e71749, https://doi.org/10.1002/ppul.71749.